Endoscopic cyclophotocoagulation in combined surgery of cataract and glaucoma

A.N. Kulikov,V.Y. Skvortsov,D.V. Tulin,,,,,
DOI: https://doi.org/10.25276/2312-4911-2022-5-92-96
2022-09-30
Modern technologies in ophtalmology
Abstract:Combined surgical treatment in patients with refractory glaucoma and cataract allows achieving stable compensation of intraocular pressure and having a significant improvement in visual functions. Purpose. To study of some aspects of efficacy and safety of combined endoscopic cyclophotocoagulation (ECP) with cataract phacoemulsification. Methods. 78 patients with uncompensated open-angle glaucoma at various stages. They were treated with ECP and cataract extraction. Among them were 40 (51.28 %) men and 38 (48.72 %) women. The follow-up period is from 6 to 48 months. The mean age of the patients was 73.46 years. Results. At the end of the follow-up period, there was a significant decrease in the mean IOP to 18.2 ± 1.5 mmHg, in comparison with the initial level of 24.1 ± 3.2 mmHg (p < 0.0001). At the same time, full success was achieved in 46.6 % (34 eyes). Partial success (reduction of IOP to 21 mmHg and below) was achieved in 51.3 % (40 eyes). The number of topical glaucoma drugs used also significantly decreased from 2.5 ± 1.0 to 1.9 ± 1.0 (p = 0.001). Moderately pronounced postoperative iridocyclitis found in 25.64 % of cases. Conclusion. ECP can be considered as a more significant component of the MIGS conception. Keywords: glaucoma, transscleral laser cyclodestruction, endoscopic cyclophotocoagulation, microinvasive glaucoma surgery.
What problem does this paper attempt to address?